Vonoprazan is a potassium-competitive acid blocker used in the treatment of acid-related disorders and as an adjunct to Helicobacter pylori eradication. Vonoprazan is a potassium-competitive acid blocker (PCAB) that inhibits H +, K + -ATPase-mediated gastric acid secretion.